Programmed Death Receptor 1 |
PD-1 |
Programmed Death-Ligand 1 |
PD-L1 |
Cytotoxic T-lymphocyte-associated protein 4 |
CTLA-4 |
Checkpoint Inhibition |
CPI |
Tumor Microenvironment |
TME |
Alanine Aminotransferase |
ALT |
Aspartate Aminotransferase |
AST |
Treatment-Related Adverse Events |
TRAEs |
Immune-Related Adverse Events |
iRAEs |
Reactive Oxygen Species |
ROS |
Granulocyte–Macrophage Colony Stimulating Factor |
GMCSF |
Acute Myeloid Leukemia |
AML |
Adeno-Associated Virus |
AAV |
Retroviral Replication Vectors |
RRV |
Hematopoietic Stem Cells |
HSCs |
DNA-encoded Monoclonal Antibodies |
DMAbs |